Systemic therapy of metastatic breast cancer: The truth beyond the clinical trials

Oncology

Volumn 76, Issue 4, 2009, Pages 247-253

  Gueth, Uwe ^a   Huang, Dorothy Jane ^a   Schoetzau, Andreas ^b   Holzgreve, Wolfgang ^a   Wight, Edward ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Schotzau and Simmen Institute for Biomathematics   (Switzerland)

Author keywords

Breast cancer; Chemotherapy; Distant metastases; Endocrine therapy; Systemic therapy

Indexed keywords

AMINOGLUTETHIMIDE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CAPECITABINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FULVESTRANT; GEMCITABINE; GONADORELIN AGONIST; MEGESTROL ACETATE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE;

EID: 60749122331     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000205387     Document Type: Article

References (12)

1. Bergh J, Jonsson PE, Glimelius B, Nygren P: A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 2001;40:253-281.
2. Chung CT, Carlson RW: Goals and objectives in the management of metastatic breast cancer. Oncologist 2003;8:514-520.
3. Ellis M, Hayes D, Lippman M: Treatment of metastatic breast cancer;in Harris J, Lippman M, Morrow M, Osborne K (eds): Diseases of the Breast. Philadelphia, Lippincott Williams & Wilkins, 2004, pp 1101-1159.
4. Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN: Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 2001;6:133-146.
5. Gralow JR: Optimizing the treatment of metastatic breast cancer. Breast Cancer Res Treat 2005;89(suppl 1):S9-S15.
6. Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P, Miccoli P: Metastatic breast cancer: an updating. Biomed Pharmacother 2006;60:548-556.
7. Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, Aapro M: Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8:1101-1115.
8. Chia SK, Speers CH, D'Yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'Reilly SE, Olivotto IA: The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007;110:973-979.
9. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M: Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 2004;22:3302-3308.
10. Fossati R, Confalonieri C, Torri V, Ghislandi E, Penna A, Pistotti V, Tinazzi A, Liberati A: Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 1998;16:3439-3460.
11. Stockler M, Wilcken NR, Ghersi D, Simes RJ: Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000;26:151-168.
12. Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart MJ: Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol 2002;13:197-207.